Day One Biopharmaceuticals (DAWN) Interest & Investment Income (2023 - 2025)
Historic Interest & Investment Income for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Q3 2025 value amounting to $4.6 million.
- Day One Biopharmaceuticals' Interest & Investment Income fell 1433.67% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year increase of 912.01%. This contributed to the annual value of $19.7 million for FY2024, which is 1462.73% up from last year.
- As of Q3 2025, Day One Biopharmaceuticals' Interest & Investment Income stood at $4.6 million, which was down 1433.67% from $4.7 million recorded in Q2 2025.
- Day One Biopharmaceuticals' 5-year Interest & Investment Income high stood at $6.1 million for Q4 2024, and its period low was $3.4 million during Q2 2023.
- Its 3-year average for Interest & Investment Income is $4.8 million, with a median of $4.8 million in 2023.
- Its Interest & Investment Income has fluctuated over the past 5 years, first surged by 2046.18% in 2024, then plummeted by 1433.67% in 2025.
- Over the past 3 years, Day One Biopharmaceuticals' Interest & Investment Income (Quarter) stood at $5.0 million in 2023, then increased by 20.46% to $6.1 million in 2024, then decreased by 24.67% to $4.6 million in 2025.
- Its last three reported values are $4.6 million in Q3 2025, $4.7 million for Q2 2025, and $5.1 million during Q1 2025.